
Currently out of the existing stock ratings of Jonathan Chang, 110 are a BUY (67.9%), 52 are a HOLD (32.1%).
Analyst Jonathan Chang, has had 51.71% of price targets met with an average potential upside of 31.38%, reached in 214 days on average.
Jonathan Chang has documented 302 price targets and ratings displayed on 24 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on REPL, at 03-Aug-2026.
Analyst best performing recommendations are on IMGN.
The best stock recommendation documented was for RVMD on 4/13/2026. The price target of $147 was fulfilled within 1 day with a profit of $10.7 (7.85%), with a performance score of 78.5.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
$1
$4
3 years 3 months 8 days ago
(10-Aug-2023)
3/4 (75%)
$0.18 (21.95%)
245
Buy
$5
3 years 10 months 15 days ago
(03-Jan-2023)
0/2 (0%)
$3.33 (199.40%)
Buy
$9
$9
4 years 9 days ago
(09-Nov-2022)
2/3 (66.67%)
$1.29 (98.13%)
340
Hold
$3
4 years 6 months 9 days ago
(09-May-2022)
1/5 (20%)
$1.46 (94.81%)
377
Buy
$6
$16
7 years 6 months 11 days ago
(07-May-2019)
1/3 (33.33%)
$6.36 (92.59%)
388